Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children

Indian Pediatrics

Volumn 46, Issue 10, 2009, Pages 883-885

  Bopche, Ankur Vikas ^a   Dwivedi, Rashmi ^a   Mishra, Rakesh ^a   Patel, G S ^a  

^a Kamla Nehru Hospital   (India)

Author keywords

Ferrous sulfate; Hemoglobin; Iron deficiency anemia; Iron polymaltose complex

Indexed keywords

FERROUS SULFATE; HEMOGLOBIN; IRON POLYMALTOSE; MUMFER; NESFOL; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HEMOGLOBINS; HUMANS; INFANT; MALE;

EID: 70350452167     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Nestel P, Alnwick D. Iron-micronutrient supplements for young children. Summary and conclusions of a consultation held at UNICEF, Copenhagen, August 19-20, 1996.
2. Borbolla JR, Cicero RE, Dibildox MM, Sotres DR, Gutierrez RG. IPC vs. Iron sulphate in the treatment of iron deficiency in infants. Rev Mex Padiatr 2000; 67: 63-67.
3. Jacobs P. Oral iron therapy in human subjects: comparative absorption between ferrous salts and iron polymaltose. J Med 1984; 3: 387-1377 (Pubitemid 15006117)
4. Arvas A, Gur E. Are ferric compound useful in treatment of IDA? Turk J Pediatr 2000;42:352-353.
5. Langstaff RJ, Geisser P, Heil WG, Bowdler JM. Treatment of IDA: a lower incidence of adverse effects with IPC than FS. Brit J Clin Res 1993; 4: 191-198.
6. Sozmen EY, Kavakli K, Cetinkaya B, Akcay YD, Yilmaz D, Aydinok Y. Effects of iron (II) salts and iron (III) complexes on trace element status in children with iron-deficiency anemia. Biol Trace Elem Res 2003; 94: 79-86. (Pubitemid 36976459)
7. Mehta BC. Ineffectiveness of iron polymaltose in treatment of IDA. J Assoc Physicians India 2003; 51: 419-421.
8. Nielsen P, Gubbe EE, Fischer R, Heinrich HC. Bioavailability of iron from ferric polymaltose in human. Drug Res 1994; 44: 743-748. (Pubitemid 24210107)
9. Heinrich HC. Intestinal iron absorption of 59 Fe from neutron activated commercial iron (III) citrate and iron (III) hydroxide polymaltose in humans. Drug Res 1987; 37: 105-107.